Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype
Authors:
- Nancy NisticòNNNancy Nisticò
- Annamaria AloisioAnnamaria Aloisio
- Antonio LupiaAntonio Lupia
- Anna Maria ZimboAZAnna Maria Zimbo
- Selena MimmiSMSelena Mimmi
- Domenico MaisanoDMDomenico Maisano
- Rossella RussoRossella Russo
- Fabiola MarinoFMFabiola Marino
- Mariangela ScaliseMSMariangela Scalise
- Emanuela ChiarellaEmanuela Chiarella
- Teresa MancusoTMTeresa Mancuso
- Giuseppe FiumeGiuseppe Fiume
Open Access
Abstract
Triple-negative breast cancer (TNBC) is an aggressive malignancy characterized by the lack of expression of estrogen and progesterone receptors and amplification of human epidermal growth factor receptor 2 (HER2). Being the Epidermal Growth Factor Receptor (EGFR) highly expressed in mesenchymal TNBC and correlated with aggressive growth behavior, it represents an ideal target for anticancer drugs. Here, we have applied the phage display for selecting two highly specific peptide ligands for targeting the EGFR overexpressed in MDA-MB-231 cells, a human TNBC cell line. Molecular docking predicted the peptide-binding affinities and sites in the extracellular domain of EGFR. The binding of the FITC-conjugated peptides to human and murine TNBC cells was validated by flow cytometry. Confocal microscopy confirmed the peptide binding specificity to EGFR-positive MDA-MB-231 tumor xenograft tissues and their co-localization with the membrane EGFR. Further, the peptide stimulation did not affect the cell cycle of TNBC cells, which is of interest for their utility for tumor targeting. Our data indicate that these novel peptides are highly specific ligands for the EGFR overexpressed in TNBC cells, and thus they could be used in conjugation with nanoparticles for tumor-targeted delivery of anticancer drugs.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (MIUR-PRIN 2017MHJJ55_002)
This publication has 64 references indexed in Scilit:
- Molecular Determinants of Epidermal Growth Factor Binding: A Molecular Dynamics StudyPLOS ONE, 2013
- WeNMR: Structural Biology on the GridJournal of Grid Computing, 2012
- Rosetta FlexPepDock ab-initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their ReceptorsPLOS ONE, 2011
- Structural Evidence for Loose Linkage between Ligand Binding and Kinase Activation in the Epidermal Growth Factor ReceptorMolecular and Cellular Biology, 2010
- Management of triple negative breast cancerThe Breast, 2010
- DynaDock: A new molecular dynamics‐based algorithm for protein–peptide docking including receptor flexibilityProteins: Structure, Function, and Bioinformatics, 2009
- EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain DimerizationMolecular Cell, 2003
- Filamentous Fusion Phage: Novel Expression Vectors That Display Cloned Antigens on the Virion SurfaceScience, 1985
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983